EPITHELIOID MESOTHELIOMA
Clinical trials for EPITHELIOID MESOTHELIOMA explained in plain language.
Never miss a new study
Get alerted when new EPITHELIOID MESOTHELIOMA trials appear
Sign up with your email to follow new studies for EPITHELIOID MESOTHELIOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Immunotherapy-Chemo cocktail shows promise for mesothelioma before surgery
Disease control OngoingThis early-phase trial tested whether giving a combination of immunotherapy (atezolizumab) and chemotherapy (cisplatin and pemetrexed) before surgery, followed by more immunotherapy after surgery, is safe and feasible for people with resectable malignant pleural mesothelioma. The…
Matched conditions: EPITHELIOID MESOTHELIOMA
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 17, 2026 13:55 UTC
-
Promising drug cocktail targets tough mesothelioma
Disease control OngoingThis study tests whether adding the drug cediranib to standard chemotherapy (cisplatin and pemetrexed) can help people with malignant pleural mesothelioma, a rare and aggressive cancer of the lung lining. About 117 participants who have not had prior treatment will receive either…
Matched conditions: EPITHELIOID MESOTHELIOMA
Phase: PHASE1, PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 17, 2026 13:53 UTC